companydata.dkAlpine-Bio ApS: Financial statements 2025
CVR: 44607379
Alpine-Bio ApS (CVR 44607379) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 179,268 and a net result of DKK -61,697 compared with DKK -156,738 the year before. That is an increase of 88.9% compared with the year before. Equity amounted to DKK 621,565. The solvency ratio was 18.9%. The company had 1 employee in the financial year.
- Gross Profit
- 179,268 kr.
- Profit/Loss
- -61,697 kr.
- Equity
- 621,565 kr.
- Total Assets
- 3,293,166 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 179 t. | -62 t. | 622 t. | 1 |
| 2024 | - | 95 t. | -157 t. | 383 t. | 1 |
Find more companies like Alpine-Bio ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
As of December 2, 2025, S21 Holding ApS is registered as an owner of Alpine-Bio ApS with an ownership share of 20%.
Alpine-Bio ApS has published its annual report for 2024. Gross profit came to DKK 94,889, and the net result was DKK -156,738.
As of April 14, 2025, JUUZ ApS is registered as an owner of Alpine-Bio ApS with an ownership share of 66%.
About Alpine-Bio ApS
Alpine-Bio ApS is a Danish company of the type Anpartsselskab based in Albertslund, founded in 2024. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Søren Anker Nielsen. The company is owned by JUUZ ApS and S21 Holding ApS. In 2025, the company reported a gross profit of DKK 179,268 and a net result of DKK -61,697 compared with DKK -156,738 the year before. Equity amounted to DKK 621,565.